| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |